It refers to the effective amount of drug synthesis, including: (a) aflatoxin compounds; (b) folic acid; (c) 5-fluoro (5-FU); and (d) irinotecano, managed in a simultaneous, sequential or interval manner. It also refers to a toolkit containing the pharmacological components of these active substances in different containers. This ingredient is useful in the treatment of colorectal cancer (CRC) metabolism
展开▼